The Pilot and Feasibility (P&F) Program of the University of Massachusetts Medical School DERC has three principal goals. 1) To provide startup funding for new investigators preparing to embark on careers in diabetes- and endocrinology-related research. 2) To provide established investigators with the opportunity to develop new technologies that may enhance diabetes-related research. 3) To enable established investigators in other fields to initiate research in areas that are related to diabetes. Related to each of these goals is the provision of support and guidance that will allow P&F Program awardees to compete successfully for the extramural funding that will allow them to remain active in diabetes-related research. Since the University of Massachusetts Medical School DERC was initiated in 1983, proposals relevant to each of our goals were received. A total of 41 research proposals funded by the P&F program have been completed. Eight additional research programs funded by the P&F program remain ongoing. Over three fourths of proposal abstracts led to invitations to submit full proposals. Approximately one third of completed proposals were funded. Since the last competing renewal, twenty-two P&F proposals have been funded and/or completed. The investigators of seventeen P&F studies (excluding the five funded in 2004) have received 30 grants from external agencies totaling more than 3.5 million dollars in current year direct costs. Approximately 57 manuscripts have been published by the DERC funded P&F investigators since their P&F award. The DERC is particularly pleased to have enabled at least seven investigators trained in other fields (Chambers, Lien, Chan, Sagerstrom, Kornfeld, Tissenbaum, and Lawson) to undertake programs of research related to diabetes. The Pilot and Feasibility (P&F) Program that is part of this competitive renewal of the University of Massachusetts Medical School DERC is designed very similarly to the program that has demonstrated continuing success since the inception of the program.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-N (J1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Massachusetts Medical School Worcester
United States
Zip Code
Desai, Paurav B; San Agustin, Jovenal T; Stuck, Michael W et al. (2018) Ift25 is not a cystic kidney disease gene but is required for early steps of kidney development. Mech Dev 151:10-17
Ly, Socheata; Navaroli, Deanna M; Didiot, Marie-Cécile et al. (2017) Visualization of self-delivering hydrophobically modified siRNA cellular internalization. Nucleic Acids Res 45:15-25
Wang, Feng; McCannell, Kurtis N; Boškovi?, Ana et al. (2017) Rlim-Dependent and -Independent Pathways for X Chromosome Inactivation in Female ESCs. Cell Rep 21:3691-3699
Watkin, Levi B; Mishra, Rabinarayan; Gil, Anna et al. (2017) Unique influenza A cross-reactive memory CD8 T-cell receptor repertoire has a potential to protect against EBV seroconversion. J Allergy Clin Immunol 140:1206-1210
LeBlanc, Scott E; Wu, Qiong; Lamba, Pallavi et al. (2016) Promoter-enhancer looping at the PPAR?2 locus during adipogenic differentiation requires the Prmt5 methyltransferase. Nucleic Acids Res 44:5133-47
Wang, Feng; Shin, JongDae; Shea, Jeremy M et al. (2016) Regulation of X-linked gene expression during early mouse development by Rlim. Elife 5:
Kincaid, Eleanor Z; Murata, Shigeo; Tanaka, Keiji et al. (2016) Specialized proteasome subunits have an essential role in the thymic selection of CD8(+) T cells. Nat Immunol 17:938-45
Townsley, E; O'Connor, G; Cosgrove, C et al. (2016) Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells. Clin Exp Immunol 183:419-30
Wyss, Lena; Stadinski, Brian D; King, Carolyn G et al. (2016) Affinity for self antigen selects Treg cells with distinct functional properties. Nat Immunol 17:1093-101
Delong, Thomas; Wiles, Timothy A; Baker, Rocky L et al. (2016) Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 351:711-4

Showing the most recent 10 out of 707 publications